Transcriptome analysis of tetraploid cells identifes cyclin D2 as a facilitator of adaptation to genome doubling in the presence of p53

Molecular Biology of the Cell

Volumn 27, Issue 20, 2016, Pages 3065-3084

  Potapova, Tamara A ^a   Seidel, Christopher W ^a   Box, Andrew C ^a   Rancati, Giulia ^b   Li, Rong ^c  

^a STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA KINASE; CYCLIN D2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; PROTEIN P53; SMALL INTERFERING RNA; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTOME; ANILLIN; CONTRACTILE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A;

ANEUPLOIDY; ARTICLE; CELL PROLIFERATION; CELL VOLUME; CYTOKINESIS; DNA CONTENT; DNA DETERMINATION; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ANALYSIS; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; M PHASE CELL CYCLE CHECKPOINT; MITOSIS SPINDLE; POLYPLOIDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA SEQUENCE; TETRAPLOIDY; UPREGULATION; WESTERN BLOTTING; CELL CYCLE; CELL DIVISION; DNA REPLICATION; GENE EXPRESSION PROFILING; GENOME; METABOLISM; PHYSIOLOGY; PROCEDURES; TUMOR SUPPRESSOR GENE;

CELL CYCLE; CELL DIVISION; CONTRACTILE PROTEINS; CYCLIN D2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOKINESIS; DNA REPLICATION; GENE EXPRESSION PROFILING; GENES, P53; GENOME; POLYPLOIDY; TETRAPLOIDY; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84992151566     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E16-05-0268     Document Type: Article

References (110)

1. Abbas T, Dutta A (2009). p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9, 400-414.
2. Alvarez-Rodriguez R, Pons S (2009). Expression of the proneural gene encoding Mash1 suppresses MYCN mitotic activity. J Cell Sci 122, 595-599.
3. Andreassen PR, Lohez OD, Lacroix FB, Margolis RL (2001). Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 12, 1315-1328.
4. Balsas P, Galan-Malo P, Marzo I, Naval J (2012). Bortezomib resistance in a myeloma cell line is associated to PSMbeta5 overexpression and poly-ploidy. Leuk Res 36, 212-218.
5. Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57, 289-300.
6. Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP (2009). Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer 9, 862-873.
7. Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, Laird PW, Onofrio RC, Winckler W, Weir BA, et al. (2012). Absolute quantifca-tion of somatic DNA alterations in human cancer. Nat Biotechnol 30, 413-421.
8. Casenghi M, Mangiacasale R, Tuynder M, Caillet-Fauquet P, Elhajouji A, Lavia P, Mousset S, Kirsch-Volders M, Cundari E (1999). p53-inde-pendent apoptosis and p53-dependent block of DNA rereplication following mitotic spindle inhibition in human cells. Exp Cell Res 250, 339-350.
9. Castillo A, Morse HC 3rd, Godfrey VL, Naeem R, Justice MJ (2007). Overex-pression of Eg5 causes genomic instability and tumor formation in mice. Cancer Res 67, 10138-10147.
10. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genom-ics data. Cancer Discov 2, 401-404.
11. Chen G, Bradford WD, Seidel CW, Li R (2012). Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy. Nature 482, 246-250.
12. Chen G, Mulla WA, Kucharavy A, Tsai HJ, Rubinstein B, Conkright J, McCroskey S, Bradford WD, Weems L, Haug JS, et al. (2015). Targeting the adaptability of heterogeneous aneuploids. Cell 160, 771-784.
13. Coward J, Harding A (2014). Size does matter: why polyploid tumor cells are critical drug targets in the war on cancer. Front Oncol 4, 123.
14. Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y, Nezi L, Protopopov A, Chowdhury D, Pellman D (2012). DNA breaks and chromosome pulverization from errors in mitosis. Nature 482, 53-58.
15. Davoli T, de Lange T (2012). Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. Cancer Cell 21, 765-776.
16. Davoli T, Denchi EL, de Lange T (2010). Persistent telomere damage in-duces bypass of mitosis and tetraploidy. Cell 141, 81-93.
17. de Bruin EC, McGranahan N, Mitter R, Salm M, Wedge DC, Yates L, Jamal-Hanjani M, Shaf S, Murugaesu N, Rowan AJ, et al. (2014). Spatial and temporal diversity in genomic instability processes defnes lung can-cer evolution. Science 346, 251-256.
18. Decker T, Schneller F, Hipp S, Miething C, Jahn T, Duyster J, Peschel C (2002). Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Leukemia 16, 327-334.
19. Dewhurst SM, McGranahan N, Burrell RA, Rowan AJ, Gronroos E, Endes-felder D, Joshi T, Mouradov D, Gibbs P, Ward RL, et al. (2014). Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov 4, 175-185.
20. Duelli DM, Hearn S, Myers M P, Lazebnik Y (2005). A primate virus generates transformed human cells by fusion. J Cell Biol 171, 493-503.
21. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
22. el-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, et al. (1995). Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55, 2910-2919.
23. Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J, Sukumar S (2001). Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethyl-ation. Cancer Res 61, 2782-2787.
24. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D (2005). Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437, 1043-1047.
25. Gadea BB, Ruderman JV (2005). Aurora kinase inhibitor ZM447439 blocks chromosome-induced spindle assembly, the completion of chromosome condensation, and the establishment of the spindle integrity checkpoint in Xenopus egg extracts. Mol Biol Cell 16, 1305-1318.
26. Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, Levine DS, Rabinovitch PS, Reid BJ (1996). 17p (p53) allelic losses, 4N (G2/tetra-ploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci USA 93, 7081-7084.
27. Ganem NJ, Cornils H, Chiu SY, O'Rourke K P, Arnaud J, Yimlamai D, Thery M, Camargo FD, Pellman D (2014). Cytokinesis failure triggers hippo tumor suppressor pathway activation. Cell 158, 833-848.
28. Ganem NJ, Godinho SA, Pellman D (2009). A mechanism linking extra centrosomes to chromosomal instability. Nature 460, 278-282.
29. Ganem NJ, Storchova Z, Pellman D (2007). Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 17, 157-162.
30. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. (2013). Integrative analysis of complex cancer genomics and clinical profles using the cBioPortal. Sci Signal 6, pl1.
31. Geuns-Meyer S, Cee VJ, Deak HL, Du B, Hodous BL, Nguyen HN, Olivieri PR, Schenkel LB, Vaida KR, Andrews P, et al. (2015). Discovery of N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthio-phen-2-yl)p hthalazin-1-amine (AMG 900), a highly selective, orally bioavailable inhibitor of aurora kinases with activity against multidrug-resistant cancer cell lines. J Med Chem 58, 5189-5207.
32. Giacinti C, Giordano A (2006). RB and cell cycle progression. Oncogene 25, 5220-5227.
33. Giam M, Rancati G (2015). Aneuploidy and chromosomal instability in cancer: a jackpot to chaos. Cell Div 10, 3.
34. Giannoudis A, Evans MF, Southern SA, Herrington CS (2000). Basal kerati-nocyte tetrasomy in low-grade squamous intra-epithelial lesions of the cervix is restricted to high and intermediate risk HPV infection but is not type-specifc. Br J Cancer 82, 424-428.
35. Gisselsson D, Jin Y, Lindgren D, Persson J, Gisselsson L, Hanks S, Sehic D, Mengelbier LH, Ora I, Rahman N, et al. (2010). Generation of trisomies in cancer cells by multipolar mitosis and incomplete cytokinesis. Proc Natl Acad Sci USA 107, 20489-20493.
36. Godinho SA, Kwon M, Pellman D (2009). Centrosomes and cancer: how cancer cells divide with too many centrosomes. Cancer Metastasis Rev 28, 85-98.
37. Gordon DJ, Resio B, Pellman D (2012). Causes and consequences of aneu-ploidy in cancer. Nat Rev Genet 13, 189-203.
38. Guidotti JE, Bregerie O, Robert A, Debey P, Brechot C, Desdouets C (2003). Liver cell polyploidization: a pivotal role for binuclear hepatocytes. J Biol Chem 278, 19095-19101.
39. Hatch EM, Fischer AH, Deerinck TJ, Hetzer MW (2013). Catastrophic nuclear envelope collapse in cancer cell micronuclei. Cell 154, 47-60.
40. Hayashi MT, Karlseder J (2013). DNA damage associated with mitosis and cytokinesis failure. Oncogene 32, 4593-4601.
41. Hirano A, Kurimura T (1974). Virally transformed cells and cytochalasin B. I. The effect of cytochalasin B on cytokinesis, karyokinesis and DNA synthesis in cells. Exp Cell Res 89, 111-120.
42. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA, Young RA (2013). Super-enhancers in the control of cell identity and disease. Cell 155, 934-947.
43. Holland AJ, Cleveland DW (2009). Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol 10, 478-487.
44. Horn HF, Vousden KH (2007). Coping with stress: multiple ways to activate p53. Oncogene 26, 1306-1316.
45. Ichijima Y, Yoshioka K, Yoshioka Y, Shinohe K, Fujimori H, Unno J, Takagi M, Goto H, Inagaki M, Mizutani S, et al. (2010). DNA lesions induced by replication stress trigger mitotic aberration and tetraploidy development. PLoS One 5, e8821.
46. Igawa T, Sato Y, Takata K, Fushimi S, Tamura M, Nakamura N, Maeda Y, Orita Y, Tanimoto M, Yoshino T (2011). Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia/small lymphocytic lymphoma. Cancer Sci 102, 2103-2107.
47. Incassati A, Patel D, McCance DJ (2006). Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6. Oncogene 25, 2444-2451.
48. Kallio MJ, McCleland ML, Stukenberg PT, Gorbsky GJ (2002). Inhibition of aurora B kinase blocks chromosome segregation, overrides the spindle checkpoint, and perturbs microtubule dynamics in mitosis. Curr Biol 12, 900-905.
49. Karrman K, Andersson A, Bjorgvinsdottir H, Strombeck B, Lassen C, Olofs-son T, Nguyen-Khac F, Berger R, Bernard O, Fioretos T, et al. (2006). Deregulation of cyclin D2 by juxtaposition with T-cell receptor alpha/delta locus in t(12;14)(p13;q11)-positive childhood T-cell acute lymphoblastic leukemia. Eur J Haematol 77, 27-34.
50. Kaya A, Gerashchenko MV, Seim I, Labarre J, Toledano MB, Gladyshev VN (2015). Adaptive aneuploidy protects against thiol peroxidase defciency by increasing respiration via key mitochondrial proteins. Proc Natl Acad Sci USA 112, 10685-10690.
51. Khan SH, Wahl GM (1998). p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Res 58, 396-401.
52. Knoepfer PS, Cheng PF, Eisenman RN (2002). N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev 16, 2699-2712.
53. Koyama-Nasu R, Nasu-Nishimura Y, Todo T, Ino Y, Saito N, Aburatani H, Funato K, Echizen K, Sugano H, Haruta R, et al. (2013). The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells. Oncogene 32, 3840-3845.
54. Kuznetsova AY, Seget K, Moeller GK, de Pagter MS, de Roos JA, Durrbaum M, Kuffer C, Muller S, Zaman GJ, Kloosterman WP, et al. (2015). Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cells. Cell Cycle 14, 2810-2820.
55. Lanni JS, Jacks T (1998). Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 18, 1055-1064.
56. Linardopoulos S, Blagg J (2015). Aurora kinase inhibition: a new light in the sky? J Med Chem 58, 5186-5188.
57. Liu SC, Bassi DE, Zhang SY, Holoran D, Conti CJ, Klein-Szanto AJ (2002). Overexpression of cyclin D2 is associated with increased in vivo invasiveness of human squamous carcinoma cells. Mol Carcinog 34, 131-139.
58. Liu G, Yong MY, Yurieva M, Srinivasan KG, Liu J, Lim JS, Poidinger M, Wright GD, Zolezzi F, Choi H, et al. (2015). Gene essentiality is a quanti-tative property linked to cellular evolvability. Cell 163, 1388-1399.
59. Loewer A, Batchelor E, Gaglia G, Lahav G (2010). Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells. Cell 142, 89-100.
60. Lv XB, Liu CY, Wang Z, Sun Y P, Xiong Y, Lei QY, Guan KL (2015). PARD3 induces TAZ activation and cell growth by promoting LATS1 and PP1 interaction. EMBO Rep 16, 975-985.
61. Macdonald JI, Dick FA (2012). Posttranslational modifcations of the retino-blastoma tumor suppressor protein as determinants of function. Genes Cancer 3, 619-633.
62. Margolis RL, Lohez OD, Andreassen PR (2003). G1 tetraploidy checkpoint and the suppression of tumorigenesis. J Cell Biochem 88, 673-683.
63. Mill P, Mo R, Fu H, Grachtchouk M, Kim PC, Dlugosz AA, Hui CC (2003). Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development. Genes Dev 17, 282-294.
64. Minn AJ, Boise LH, Thompson CB (1996). Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev 10, 2621-2631.
65. Mo JS, Yu FX, Gong R, Brown JH, Guan KL (2012). Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev 26, 2138-2143.
66. Moon JJ, Rubio ED, Martino A, Krumm A, Nelson BH (2004). A permissive role for phosphatidylinositol 3-kinase in the Stat5-mediated expression of cyclin D2 by the interleukin-2 receptor. J Biol Chem 279, 5520-5527.
67. Nigg EA (2002). Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2, 815-825.
68. Nigg EA (2006). Origins and consequences of centrosome aberrations in human cancers. Int J Cancer 119, 2717-2723.
69. Ohshima S, Seyama A (2013). Establishment of proliferative tetraploid cells from normal human fbroblasts. Front Oncol 3, 198.
70. Olaharski AJ, Sotelo R, Solorza-Luna G, Gonsebatt ME, Guzman P, Mohar A, Eastmond DA (2006). Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 27, 337-343.
71. Olivier M, Hollstein M, Hainaut P (2010). TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2, a001008.
72. Ornitz DM, Hammer RE, Messing A, Palmiter RD, Brinster RL (1987). Pan-creatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science 238, 188-193.
73. Orth JD, Loewer A, Lahav G, Mitchison TJ (2012). Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction. Mol Biol Cell 23, 567-576.
74. Oshimo Y, Nakayama H, Ito R, Kitadai Y, Yoshida K, Chayama K, Yasui W (2003). Promoter methylation of cyclin D2 gene in gastric carcinoma. Int J Oncol 23, 1663-1670.
75. Panopoulos A, Pacios-Bras C, Choi J, Yenjerla M, Sussman MA, Fotedar R, Margolis RL (2014). Failure of cell cleavage induces senescence in tetraploid primary cells. Mol Biol Cell 25, 3105-3118.
76. Payton M, Bush TL, Chung G, Ziegler B, Eden P, McElroy P, Ross S, Cee VJ, Deak HL, Hodous BL, et al. (2010). Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activ-ity in taxane-resistant tumor cell lines. Cancer Res 70, 9846-9854.
77. Piekny AJ, Glotzer M (2008). Anillin is a scaffold protein that links RhoA, actin, and myosin during cytokinesis. Curr Biol 18, 30-36.
78. Potapova TA, Unruh JR, Box AC, Bradford WD, Seidel CW, Slaughter BD, Sivagnanam S, Wu Y, Li R (2015). Karyotyping human and mouse cells using probes from single-sorted chromosomes and open source software. Biotechniques 59, 335-346.
79. Potapova TA, Zhu J, Li R (2013). Aneuploidy and chromosomal instability: a vicious cycle driving cellular evolution and cancer genome chaos. Cancer Metastasis Rev 32, 377-389.
80. Puig PE, Guilly MN, Bouchot A, Droin N, Cathelin D, Bouyer F, Favier L, Ghiringhelli F, Kroemer G, Solary E, et al. (2008). Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy. Cell Biol Int 32, 1031-1043.
81. Robinson MD, McCarthy DJ, Smyth GK (2010). edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140.
82. Rojas A, Kong SW, Agarwal P, Gilliss B, Pu WT, Black BL (2008). GATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart feld-derived myocardium. Mol Cell Biol 28, 5420-5431.
83. Salic A, Mitchison TJ (2008). A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc Natl Acad Sci USA 105, 2415-2420.
84. Sarkar R, Hunter IA, Rajaganeshan R, Perry SL, Guillou P, Jayne DG (2010). Expression of cyclin D2 is an independent predictor of the development of hepatic metastasis in colorectal cancer. Colorectal Dis 12, 316-323.
85. Selmecki AM, Dulmage K, Cowen LE, Anderson JB, Berman J (2009). Ac-quisition of aneuploidy provides increased ftness during the evolution of antifungal drug resistance. PLoS Genet 5, e1000705.
86. Selmecki A, Forche A, Berman J (2006). Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 313, 367-370.
87. Sharma S, Zeng JY, Zhuang CM, Zhou YQ, Yao H P, Hu X, Zhang R, Wang MH (2013). Small-molecule inhibitor BMS-777607 induces breast cancer cell polyploidy with increased resistance to cytotoxic chemotherapy agents. Mol Cancer Ther 12, 725-736.
88. Shen H, Perez RE, Davaadelger B, Maki CG (2013). Two 4N cell-cycle arrests contribute to cisplatin-resistance. PLoS One 8, e59848.
89. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, et al. (1996). Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384, 470-474.
90. Taylor S, Peters JM (2008). Polo and Aurora kinases: lessons derived from chemical biology. Curr Opin Cell Biol 20, 77-84.
91. Terashima K, Yu A, Chow WY, Hsu WC, Chen P, Wong S, Hung YS, Suzuki T, Nishikawa R, Matsutani M, et al. (2014). Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors. Pediatr Blood Cancer 61, 593-600.
92. Thompson DA, Desai MM, Murray AW (2006). Ploidy controls the success of mutators and nature of mutations during budding yeast evolution. Curr Biol 16, 1581-1590.
93. Tse YC, Piekny A, Glotzer M (2011). Anillin promotes astral microtubule-directed cortical myosin polarization. Mol Biol Cell 22, 3165-3175.
94. Uetake Y, Sluder G (2004). Cell cycle progression after cleavage failure: mammalian somatic cells do not possess a "tetraploidy checkpoint." J Cell Biol 165, 609-615.
95. Uetake Y, Sluder G (2010). Prolonged prometaphase blocks daughter cell proliferation despite normal completion of mitosis. Curr Biol 20, 1666-1671.
96. Vassilev LT, Tovar C, Chen S, Knezevic D, Zhao X, Sun H, Heimbrook DC, Chen L (2006). Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc Natl Acad Sci USA 103, 10660-10665.
97. Vassilev LT, Vu B T, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, et al. (2004). In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844-848.
98. Vitale I, Senovilla L, Jemaa M, Michaud M, Galluzzi L, Kepp O, Nanty L, Criollo A, Rello-Varona S, Manic G, et al. (2010). Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos. EMBO J 29, 1272-1284.
99. Vogelstein B, Lane D, Levine AJ (2000). Surfng the p53 network. Nature 408, 307-310.
100. Vousden KH, Lane DP (2007). p53 in health and disease. Nat Rev Mol Cell Biol 8, 275-283.
101. Wang Y, Toppari J, Parvinen M, Kallio MJ (2006). Inhibition of Aurora kinases perturbs chromosome alignment and spindle checkpoint signaling in rat spermatocytes. Exp Cell Res 312, 3459-3470.
102. Wong C, Stearns T (2005). Mammalian cells lack checkpoints for tetra-ploidy, aberrant centrosome number, and cytokinesis failure. BMC Cell Biol 6, 6.
103. Yamak A, Latinkic BV, Dali R, Temsah R, Nemer M (2014). Cyclin D2 is a GATA4 cofactor in cardiogenesis. Proc Natl Acad Sci USA 111, 1415-1420.
104. Yamak A, Temsah R, Maharsy W, Caron S, Paradis P, Aries A, Nemer M (2012). Cyclin D2 rescues size and function of GATA4 haplo-insuffcient hearts. Am J Physiol Heart Circ Physiol 303, H1057-H1066.
105. Yang D, Welm A, Bishop JM (2004). Cell division and cell survival in the absence of survivin. Proc Natl Acad Sci USA 101, 15100-15105.
106. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, Fu XD, et al. (2012). Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780-791.
107. Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, Lawrence MS, Zhsng CZ, Wala J, Mermel CH, et al. (2013). Pan-cancer patterns of somatic copy number alteration. Nat Genet 45, 1134-1140.
108. Zarkowska T, Mittnacht S (1997). Differential phosphorylation of the retino-blastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 272, 12738-12746.
109. Zhang S, Mercado-Uribe I, Xing Z, Sun B, Kuang J, Liu J (2014). Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene 33, 116-128.
110. Zhong W, Mao S, Tobis S, Angelis E, Jordan MC, Roos K P, Fishbein MC, de Alboran IM, MacLellan WR (2006). Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway. EMBO J 25, 3869-3879.